I have seen some license deal where the company gets a cash upfront payment plus an equity deal to strength their balance sheet. Furthermore, pay for all costs associated for future phase III clinical trials. Any mention of future royalty which is generally 10-15% and the sp will fly immediately to the moon. But you could also be right about cap-rise, time will tell.
I have seen some license deal where the company gets a cash...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.002(3.70%) |
Mkt cap ! $50.52M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 5.2¢ | $51.10K | 945.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4281 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 625000 | 2 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.6¢ |
Change
0.002 ( 3.70 %) |
||||
| Open | High | Low | Volume | ||
| 5.2¢ | 5.6¢ | 5.2¢ | 183067 | ||
| Last updated 15.53pm 06/05/2024 ? | |||||
| BIT (ASX) Chart |